Press Releases

All Releases
View Summary ARYx Therapeutics Schedules First Quarter 2008 Results and Earnings Call and Clarifies Expiration of Lock-Up Period
Apr 30, 2008
PDF 12.3 KB Add to Briefcase
View Summary ARYx to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
Apr 25, 2008
PDF 10.5 KB Add to Briefcase
View Summary ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia
Apr 22, 2008
PDF 13.4 KB Add to Briefcase
View Summary ARYx Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results
Mar 12, 2008
PDF 20.4 KB Add to Briefcase
View Summary ARYx Therapeutics Schedules Fourth Quarter and Year End 2007 Results and Earnings Call
Mar 6, 2008
PDF 9.9 KB Add to Briefcase
View Summary ARYx Therapeutics Provides Update on Product Development -- Reports Results for 2007 Third Quarter
Dec 20, 2007
PDF 22.4 KB Add to Briefcase
View Summary ARYx Therapeutics Schedules Third Quarter 2007 Results and Earnings Call
Dec 12, 2007
PDF 9.8 KB Add to Briefcase
View Summary ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering
Nov 7, 2007
PDF 9.3 KB Add to Briefcase
View Summary ARYx Therapeutics Files Registration Statement for Initial Public Offering
Aug 30, 2007
PDF 8.8 KB Add to Briefcase
View Summary ARYx Therapeutics Appoints New Chief Development Officer
Feb 21, 2007
PDF 9.1 KB Add to Briefcase
View Summary ARYx Therapeutics President & Co-Founder Elected to California Healthcare Institute Board
Nov 15, 2006
PDF 9.8 KB Add to Briefcase
View Summary ARYx Therapeutics President & Co-Founder Elected to California Healthcare Institute Board
Nov 15, 2006
PDF 9.2 KB Add to Briefcase
View Summary Procter & Gamble Pharmaceuticals and ARYx Therapeutics Form Alliance for an Investigational Treatment for Gastrointestinal Disorders
Jul 11, 2006
PDF 14.4 KB Add to Briefcase
View Summary Procter & Gamble Pharmaceuticals and ARYx Therapeutics Form Alliance for an Investigational Treatment for Gastrointestinal Disorders
Jul 11, 2006
PDF 14.4 KB Add to Briefcase
View Summary ARYx Therapeutics Appoints Herm Rosenman to Board of Directors
Feb 21, 2006
PDF 9.6 KB Add to Briefcase
View Summary ARYx Therapeutics Appoints Herm Rosenman to Board of Directors
Feb 21, 2006
PDF 9.3 KB Add to Briefcase
View Summary ARYx Therapeutics Completes Series E Financing
Feb 7, 2006
PDF 10.3 KB Add to Briefcase
View Summary ARYx Therapeutics Completes Series E Financing
Feb 7, 2006
PDF 9.6 KB Add to Briefcase
View Summary ARYx Therapeutics Appoints Former Amgen Exec to Board
Aug 18, 2005
PDF 9.6 KB Add to Briefcase
View Summary ARYx Therapeutics Appoints Former Amgen Exec to Board
Aug 18, 2005
PDF 9.3 KB Add to Briefcase
Showing 1-20 of 33 Page: 1 2  Next 20
= add release to Briefcase
Stock Information
NASD:ARYX
$6.23   + 0.19
May 9, 2008
4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by TurboFeed.
 ARYx Therapeutics Final
     Prospectus

Corporate Presentation

Learn more about our products, technology, and financial history by viewing our Corporate Presentation.

Learn More